AAVantgarde
Cell & Gene Therapy · Rare Disease Therapeutics
2open roles
$141Mlatest round · Series B · Nov 2025 · 12 mo ago
3backers · Atlas Venture, Neva SGR
200+team · employees, estimated range
Overview
AAVantgarde is a clinical-stage biotechnology company developing next-generation therapies for inherited retinal diseases with high unmet need.
Funding and backers
Total raised
$141M
1 round on record
Latest round
$141M
Series B · Nov 2025 · 12 mo ago
Team
201-500
employees, estimated range
Hiring now
2
+2 posted in 30 days
Backers
3
Atlas Venture, Neva SGR
The money's age
Due for its next round
12 months since the last round · and hiring
Momentum
42/100
hiring for its size, in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1
New executive AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer · markets.businessinsider.com
Jan 4
New executive AAVantgarde appoints Philip Lao as Senior Vice President of Business Development · FinanzNachrichten.de
Nov 7, 2025
Raised a round Series B $141M · led by Schroders · Pulse 2.0
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Nov 2025 | $141M | Schroders lead, Atlas Venture lead, Forbion lead | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Atlas Venture 
Neva SGR 
Sofinnova Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Overview. Ambros Therapeutics, headquartered in San Diego, California, is a clinical-stage biotechnology company focused on the development…
Redefining Complement Therapies. Complement Therapeutics is a clinical-stage biotechnology company advancing precision therapies for…
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been…
Tessera Therapeutics is a biotechnology company pioneering Gene Writing technology to develop genetic medicines. It is developing in vivo…
Signadori Bio is a preclinical stage biopharmaceutical company developing a next generation in vivo monocyte immunotherapy to treat solid…
Jobs
≈ $45k – $100k per year (Estimated) · In office · Bachelor's Degree · London
SharePoint
Apply
≈ $82k – $162k per year (Estimated) · In office · Bachelor's Degree · London
Apply
Growth
Hiring Momentum
32/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
Median time-to-fill
77 days
faster than 15% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Management
67% ▲
Sales
33% ▼
Activity Timeline
Added ICH Guidelines to stack
Oct 2026
Added SharePoint to stack
Oct 2026
Added Microsoft Teams to stack
Oct 2026
Financials
Total raised
$141M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2025 | $141M | Details |
Tech stack
Technologies named in job postings at AAVantgarde over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
1
Stack modernity
57/100
Languages
Python
SAS
Practices & domains
ICH Guidelines
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Braveheart, AAVantgarde rounds head recent biofinancings
Our latest crop of biotech financings has nine-figure rounds for Braveheart and AAVantgarde, with Azalea Therapeutics and NEOK Bio also raising funds.
Read more
Report
AAVantgarde appoints Megan Zoschg Canniere as Chief Regulatory & Quality Officer
MILAN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherit...
Read more
Report
Beyond BioNTech: Inside the Strüngmann Portfolio in 2026 (Antheia, AAVantgarde, Doctolib, and the Next Decade)
What the Strüngmann brothers are funding now - Antheia, AAVantgarde Bio, Doctolib, Immatics, Tubulis - and what it signals about the next decade of DACH biotech.
Read more
Report
AAVantgarde to Participate in ARVO 2026, with Presentations at Key Pre-events and New Clinical Data from the LUCE Phase 1/2 Study
MILAN, April 23, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today
Read more
Report
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development
MILAN, April 01, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherited retinal diseases (IRDs) focused on large gene delivery
Read more
Report
AGC Biologics to Manufacture AAVantgarde's Dual-Vector Gene Therapies for Inherited Retinal Disorders
Read more
Report
AAVantgarde: $141 Million Series B Closed To Advance Clinical Programs For Stargardt Disease And Usher 1B Syndrome
AAVantgarde Bio has closed a $141 million (€122 million) Series B financing to advance its lead clinical programs targeting inherited retinal diseases. The financing round was co-led by Schroders Capital, Atlas Venture, and Forbion, with participation fro
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
1
Countries
2
Busiest office
London
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Varese
Italy
HQ
Rome
London
United Kingdom
Regional office
London
2 open roles 3 posted in 90 days 200-500 est. staff
hires for Management
Pozzuoli
Italy
Regional office
Naples